Rapport Therapeutics

IPO

Public · Boston, United States · Founded 2022 · $250.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$250.0M
Last Round
$150.0M Series BAug 2023
Rounds
2
Type
Public

About

Rapport Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded in 2022 and headquartered in Boston, Massachusetts. The company is pioneering a precision medicine approach to neuroscience through its proprietary RAP (Receptor-Associated Protein) technology platform, which enables neuroanatomically precise targeting of GABA-A receptor subtypes. Rapport completed its IPO on Nasdaq (ticker: RAPP) in July 2024.

Summary

Rapport Therapeutics is a Biotech company based in Boston, United States, founded in 2022. It has raised $250.0M in total across 2 rounds, most recently a $150.0M Series B round in Aug 2023. Investors include Cormorant Asset Management, Third Rock Ventures and Johnson & Johnson Innovation.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJun 2024
$174.0M

Sign up to see all 3 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rapport Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/rapport-therapeutics"><img src="https://indexed.vc/api/badge/company/rapport-therapeutics" alt="Rapport Therapeutics on Indexed.vc" width="260" height="76" /></a>